Lancor Scientific (PRIVATE-UK:LANCO)

Lancor Scientific (PRIVATE-UK:LANCO)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Lancor Scientific

The Lancor Blockchain Platform (LBP)

The Lancor Blockchain Platform (LBP) blockchain architecture provides the opportunity for trusted, verifiable, and auditable data, adding a greater level of authenticity to any data generated within its infrastructure.

Our blockchain implementation offers “potential solutions” to many of the issues raised by the WHO. One of the major features of...

EPIC: LANCO
Market: PRIVATE-UK:LANCO
Sector: Pharma & Biotech
Website: www.lancorscientific.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Lancor Scientific


Lancor Scientific Snapshot

Our mission:

is to Find Cancer Early.

Our vision:

is that early diagnosis and screening will be available to everyone, everywhere.

Aamir Butt, CEO:

Building a tested customer centric go-to-market strategy and executing it through focused organisational alignment is in Aamir’s DNA. With 20-years of experience of starting and selling his own businesses, and supporting over 90 other businesses, taking new products to new markets is at the heart of his expertise. Aamir has built scalable business models across several verticals including health, medtech, digital and service industries. Goal-focused and results-oriented, Aamir uses tools and processes effectively and he also teaches, consults and coaches.

Dr. Donald de Korte – Head of Marketing & Global Access:

Donald is a Medical Doctor and Epidemiologist with 30+ years in Synthélabo (Sanofi), Servier, MSD, Novartis, the Bill & Melinda Gates Foundation, and the International Diabetes Federation. Founder of the African Comprehensive HIV/AIDS Partnership in Botswana, and the Ibani-Se HIV/AIDS Initiative in Nigeria, his leadership style is described in external reviews as "can do".

Prof. Dr. Roland Schlesinger, Head of R&D & Chief Medical Officer:

Roland has over 25 years of Research and Development leadership experience in the pharmaceutical and MedTech industry with a strong focus on risk management and pharmacovigilance. He is an author and co-author of several books and guides for the pharmaceutical industry and healthcare. Roland translates complex scientific discoveries into practical applications to help to understand, diagnose and treat complex cancerous disorders and promotes the cutting-edge technology of early cancer screening by the use of precision and personalized medicine. Roland leads the Academic Research Network (ARN) and is the Medical Director of the International Interdisciplinary Research Center (IIRC) at the Sigmund Freud University in Vienna. He is also a Member of the Interdisciplinary Austrian Blockchain Research Group at Secure Business Austria Research. Roland is also a member of the Board of Directors at Insud Pharma Group. He studied medicine at the University of Vienna, and in Paris and Moscow, Management at the Vienna University of Economics and Business.

Rory Lavelle, Chief Commercial Officer:

Rory is proven and passionate sales leader with over 30 years commercial experience in both the Information Technology and Telecommunications markets. A graduate in Electronic Engineering, he quickly moved into the commercial world where he progressed through roles such as Applications Engineering; Product Management; Business Management; General Management through to his last role as a V.P of Sales and Marketing in a billion dollar USA company, in the Telecommunications sector. He spent the last 23 years building and leading Sales & Marketing teams in Europe & Africa, culminating in his most recent role in directing and leading the entire European and African teams, responsible for c$200m of revenue. He has strong experience in both B2B & B2C environments with most experience in driving Distribution & Reseller acquisition and development strategies & regional Go To Market Models, and more latterly building high-touch large end-user focused sales teams too.

 

 

Address:
Lancor Scientific
1 Primrose Street
London EC2A 2EX
E: hello(at)lancorscientific.com

Address:
Lancor Scientific Cancer Research Laboratory
Technical University Graz   Inffeldgasse 25e
4. Floor, ME04014
8010 Graz, Austria

Address:
Lancor Scientific
D6 Thane Rd
Nottingham
NG90 6BH

Dr Khalil Razvi, MB BCh

is a highly qualified surgeon, his eminence in the field of gynaecological cancer diagnostics is complemented by his background in innovation in medicine, having acted as co-inventor for two patents in the field. Khalil has undertaken active research with over 30 peer-reviewed publications and over 50 Conference publications. He also holds many leadership roles in the NHS including Clinical Director for the Obs & Gynae department and Director for Women & Children, the lead Colposcopist in Southend Hospital, and leads the Gynaecological Oncology service for South Essex. Dr Khalil's main responsibility is to offer advice and guidance from outside the company.

Professor Dr. A Min Tjoa

Professor Dr. A Min Tjoa has been a full professor and director of the Institute of Software Technology and Interactive Systems at the Vienna University of Technology since 1994. He is the chairperson and board member for committees including, Christian Doppler Foundation for the establishment of high-technology transfer labs in Austria, DEXA Association and is currently the chairman of the Austrian National Competence Center for Security Research. Professor Dr. A Min Tjoa is currently member of the Council of Doctoral Studies in Mathematics, Informatics and Telecommunication which covers all universities in the Toulouse area. He is currently focusing on researching data warehousing, cloud computing, semantic web, security, and non-standard IT-applications.

Professor Dr. Christian Baumgartner

Christian Baumgartner, PhD has been Professor and Head of the Institute of Health Care Engineering with European Testing Center of Medical Devices at Graz University of Technology, Austria. He received his MSc and PhD degree from Graz University of Technology, his habilitation degree (Assoc.-Prof.) in Biomedical Engineering from UMIT, Austria. From 1998-2002 Dr. Baumgartner held an R&D position at Tecan Group AG, where he co-developed DNA microarray scanning systems. From 2007-2008, he joined the Barnett Institute of Chemical and Biological Analysis, Northeastern University and Harvard Medical School, Boston, MA, where Dr. Baumgartner worked in the field of bioinformatics for biomarker discovery. In 2009, he was appointed Full Professor at UMIT and in 2015 Professor at Graz University of Technology. Dr. Baumgartner is the author of more than 150 publications and is a reviewer for more than 40 scientific journals. His research in biomedical engineering focuses on cellular electrophysiology and clinical bioinformatics, biomedical sensors, modeling and simulation and medical device regulation.

Freidrich Schmidl

Friedrich Schmidl has worked for the ABA-Invest in Austria, the official business Location Agency, since 1989. He is the Director responsible for the German market and the field of Life Sciences. Mr. Schmidl holds further functions as a Member of the Supervisory Board of Dynasafe Austria GmbH and as a Member of the Advisory Board of LISA – Life Science Austria. He is also a Colonel in the Austrian Federal Army in the field of international strategy.

Friedrich Schmidl was born on 10.03.1953 in Austria, is married and has three grown up children. After an extensive economics and business education, he works in the field of Business Location and Investment Services as a Business Location Consultant.

Address:
Lancor Scientific
1 Primrose Street
London EC2A 2EX
E: hello(at)lancorscientific.com

Address:
Lancor Scientific Cancer Research Laboratory
Technical University Graz   Inffeldgasse 25e
4. Floor, ME04014
8010 Graz, Austria

Address:
Lancor Scientific
D6 Thane Rd
Nottingham
NG90 6BH

Lancor Scientific Timeline

Videos

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use